Total raised
$63.9M
Last: PIPE 2023-09
Stage
Public
Founded
2003
Headcount
32
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
Scinai Immunotherapeutics is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases.
With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs.
Funding history · 3 rounds · $63.9M total
2023-09
PIPE
$1.3M
2019-07
PIPE
$16.7M
2017-01
PIPE
$2.9M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsLife SciencesPharmaceuticals
Business model
B2B2CB2B
Highlights
1 PatentsVerified
Tags
immunotherapyautoimmune-diseasespharmaceuticalsviral-diseasesbiotechnologytherapeuticsinfectious-diseasedrug-discoverytreatmentsdrug-deliverybiopharmaceuticalvaccinespatientsnanotechnology